Our mission is to remove technical barriers so you can bring your most ambitious discoveries to life. With our cutting-edge platform, you can accelerate and simplify your mass spec workflows, develop better and faster assays to streamline drug discovery, and reduce development time and costs to push the boundaries of your research.
Andson Biotech is an Atlanta-based biotechnology company that was formed to broaden access to mass spectrometry for mainstream use in the advanced biotherapeutic space.
Led by Dr. Mason Chilmonczyk, Co-Founder and CEO, who developed a breakthrough technology during his PhD studies at Georgia Tech with Professor Andrei Fedorov (Co-Founder and Board Member), Andson aims to accelerate therapeutic development, reduce costs, and ultimately make lifesaving treatments more accessible to patients.
Our bold and talented team of bioscientists, mass spectrometrists, engineers, and tech enthusiasts are united by their desire to transform biotherapeutics discovery, development, and manufacturing. We believe that with the right biotools available…anything is possible.
